Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Aeterna Zentaris Inc (AEZS)

Toronto
Currency in CAD
Disclaimer
2.660
0.000(0.00%)
Closed

AEZS Comments

Sold ?
going up again........time to BUY?
bull time now though
Can we see this below $2 today ??
It already was...
Time to pick up the end of the day rally. Profit takers and weak hands are shaken off now.
It seems we are going up again.
Oral vaccine for covid,, what else do you want?
Somebody wants *****vaccine
vaxart completely failed at their stage 1 testing for oral vaccine for covid, so it is clearly difficult
Options Traders Expect Huge Moves In Aeterna Zentaris (AEZS) Stock
up or down?
Another product AEZS aside from COVID medicaton.........According to recent news, Aeterna Zentaris Inc. continues to advance discussions in securing a commercialization partner for macimorelin in Europe and other key global markets.
the price is now peanuts so
buy, buy, buy, and push this higher my friends. so much potential.
Stanko are yoi here?
I heard that strongest apes come from some city of Sesvete? Am I wrong?  There is a word circling that half of those guys have diamond hands.
thats true
 Thank you my friend.
Chance to pile up a little more. Normal after yesterday's 200%.
i am buying more for sure
just hold........sellers just enjoying....it will burst again for more or buy for more from the current dip
the big picture is coming after market don't worry guys just know we catch it on time let's go to the 🌙 i will buy more another 20k I set it for 2.15 🙏 let's go
Any hopes?
maybe?
Aeterna Zentaris Inc. (AEZS) Unique Oral Vaccine Technology Sir Charles A. Henriques https://twitter.com/CharlesAHenriq1 Best in class technology from a German university Clinical trails, news from government officials expected soon.
This have so much potential
y prediction, $6.00 to $10 by Friday. Happy Valentine's Day. News next Monday, perhaps partnership. Aeterna Zentaris Inc. (AEZS) notes that the oral vaccine shows promise and wants to move forward with human trials. Needle-free vaccines are attractive as they cause less pain and stress to people with needle phobias. Benefits, easy pill, room temperature storage, faster transportation and no cold storage.
https://twitter.com/CharlesAHenriq1
nice move 👏 i bought yesterday in the top at 3,52$ 🥴😅💪🚀🚀🚀🔝🔝🔝
just wait NASDAQ bull can go till mid March
Bullish pattern forming
There is more to come for AEZS.......Based on the report that Aeterna Zentaris Inc is announcing a European licensing agreement with consilient Health ltd. for the commercialization of Macimorelin. Check the disclaimer on the landing page. However, these other industries are said that prospector reef a historic gold min could associate with structurally-controlled quartz veins. Read more of it here and you could see this amazing trend that you don't want to miss out on! https://prem.li/MustSee-GoldMarket
TNXP meant to close +15% today
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.